Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) that are larger than normal. Until now, this was considered a sign that the cancer was ...

U of A Comprehensive Cancer Center Director Dr. Dan Theodorescu plans to study loss of Y chromosome biology and investigate ...

BAMF Health in Grand Rapids is offering an alternative treatment for prostate cancer that doesn't involve chemotherapy.

New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically removing them along with tumors may weaken treatment, while preserving them ...

The Incucyte ® Cytotoxicity Assay uses the Incucyte ® Cytotox Dyes and the Incucyte ® Live-Cell Analysis System to evaluate ...

Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead. Now, researchers at the UCLA Health Jonsson Comprehensive ...

The deadliest type of brain cancer does something doctors didn't expect: it thins the skull. New research shows glioblastoma goes beyond just attacking the brain; it also weakens the bone protecting ...

For the first time, researchers have successfully fabricated and characterized a fully functional mirror-image nanopore—a ...